Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Bladder Instillation for Prevention of Catheter Associated UTIs
NCT04077749Phase 1Withdrawn
- Sponsor
- Lahey Hospital & Medical Center
- Start
- Apr 2021
- Primary completion
- Jun 2021
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 1, randomised, double-blind trial of Femdophilus in urinary tract infection (UTI) (2 arms), sponsored by Lahey Hospital & Medical Center. Primary endpoint: Bladder colonization with Lactobacillus at 6 months. Planned start Apr 2021; status: withdrawn.
02
Drugs
Femdophilus
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04077749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04077749.